mk 0663 has been researched along with valproate sodium in 1 studies
| Studies (mk 0663) | Trials (mk 0663) | Recent Studies (post-2010) (mk 0663) | Studies (valproate sodium) | Trials (valproate sodium) | Recent Studies (post-2010) (valproate sodium) |
|---|---|---|---|---|---|
| 549 | 173 | 265 | 82 | 1 | 42 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumari, S; Mishra, CB; Pandey, P; Prakash, A; Tiwari, AK; Tiwari, M; Yadav, R | 1 |
1 other study(ies) available for mk 0663 and valproate sodium
| Article | Year |
|---|---|
Discovery of novel Methylsulfonyl phenyl derivatives as potent human Cyclooxygenase-2 inhibitors with effective anticonvulsant action: Design, synthesis, in-silico, in-vitro and in-vivo evaluation.
Topics: Animals; Anticonvulsants; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Drug Design; Epilepsy; Humans; Male; Methylation; Molecular Docking Simulation; Pentylenetetrazole; Rats; Rats, Wistar; Seizures; Sulfinic Acids | 2018 |